Certificate of Need (CON) regulation is one of the most consequential — and often misunderstood — variables in home health and hospice M&A. In approximately 15 states, CON requirements limit new agency entry, creating scarcity that materially affects valuation, transaction structure, and buyer behavior.
This guide explains how CON works in home-based care, which states have meaningful CON regimes, how CON affects valuations, and what sellers and buyers should understand about transactions involving CON-supported licenses.
CON regulation requires that a healthcare provider seeking to enter a market (open a new home health agency, expand into a new service area, or in some cases significantly expand existing capacity) demonstrate to the state regulator that the new service is needed in the proposed area.
The state evaluates CON applications using criteria including:
For home health and hospice in CON states, the practical effect is that new agency entry is restricted — sometimes severely. In some service areas, CON applications are rarely approved; in others, they are approved only when specific demographic or access criteria are demonstrated.
The economic consequence is scarcity. Existing licensed agencies in CON states operate in markets with limited new competition, which supports stronger pricing, higher operating margins, and premium acquisition multiples.
The CON landscape changes regularly as states reform or repeal their regimes. As of 2026, states with notable CON requirements affecting home health and hospice include:
Several states have repealed CON for some or all home-based care services in recent years. Florida repealed hospice CON effective 2025. Other states have ongoing reform discussions.
Within CON states, requirements vary:
The practical effect of any CON regime depends on how restrictively the state actually evaluates applications, not just whether CON exists on paper.
CON-state home health and hospice agencies commonly command 1.0× to 2.0× EBITDA multiple premiums vs. comparable non-CON state agencies. The premium reflects:
The premium is most pronounced in tightly restricted CON jurisdictions where new entry is rarely approved, and in service areas with strong demographic growth.
Buyers in CON states evaluate:
The agencies that command the largest CON premiums are well-run incumbents in stable CON service areas with growing demand and high utilization.
If a state repeals CON, the scarcity premium erodes over time as new entry occurs. Buyers underwriting CON-state acquisitions consider:
States with active reform discussions (or recent repeal action in adjacent states) may see partial discounting of the CON premium even before formal repeal.
The CON itself is generally tied to the licensee, but the underlying agency license transfers in a change of ownership process. Buyers acquire the licensed agency entity (or assets including the license), and the CON-supported license stays in service.
CHOW mechanics vary by state. Some states require:
CHOW timelines in CON states can be longer than in non-CON states. Plan accordingly in transaction structure.
Whether a transaction is structured as asset or stock purchase has implications for license and CON continuity:
Healthcare M&A counsel with CON state experience is essential for getting structure right.
Buyers in CON state transactions diligence:
Your CON position is one of your most valuable assets. Treat it as such:
A CON-state agency that demonstrates these well can capture the full multiple premium. An agency that takes CON for granted often leaves the premium on the table.
The market has changed. Pre-repeal valuation expectations no longer apply, and the buyer pool has shifted:
Sellers in recently-repealed states should re-anchor expectations and lean into the temporary surge in buyer interest.
CON reform discussion in your state is a relevant strategic input. If reform is likely within your sale planning horizon, going to market before reform can capture the full premium.
CON-state acquisitions are attractive for the same reasons they are valuable to sellers: defensible market position, pricing power, sustainable margins. The question for buyers is whether the premium being paid reflects appropriate underwriting of:
Sophisticated buyers build state-by-state CON intelligence as part of their acquisition strategy.
CON regimes treat services differently. Some states have CON for Medicare-certified home health but not hospice, or vice versa. Some states regulate hospice inpatient capacity (GIP beds) under CON but not routine hospice. Some have CON for skilled nursing but not home-based services.
Understanding the specific CON applicability in your state and to your service line is essential. Generic “CON state” assumptions miss the actual regulatory mechanics that drive valuation.
CON regulation creates real, measurable value for home health and hospice agencies in restricted states — typically 1.0× to 2.0× EBITDA multiple premiums. Capturing the full premium in a sale requires understanding and documenting your CON position, addressing any compliance or condition issues, and engaging buyers who understand and value CON-protected market position.
If you operate a CON-state home health or hospice agency and would like to understand how to position your CON value in a sale process, contact us for a confidential conversation.
Palliative Care Agency Valuation & M&A in 2026: Distinguished from Hospice, Different Multiples
State GuidesSelling a Home Care Agency in Colorado: 2026 Market Guide
Seller GuidesCMS Change of Ownership (CHOW) for Home Health & Hospice: A Seller's Guide
State GuidesSelling a Home Care Agency in Illinois: 2026 Market Guide
State GuidesSelling a Home Care Agency in Massachusetts: 2026 Market Guide
State GuidesSelling a Home Care Agency in Pennsylvania: 2026 Market Guide
Newsletter
Receive new articles, EBITDA benchmark updates, and deal intelligence directly in your inbox. No spam — unsubscribe anytime.
Join 1,200+ home care executives. Unsubscribe anytime.